97 related articles for article (PubMed ID: 10897014)
21. Pattern of nonspecific (or global) DNA methylation in oral carcinogenesis.
Piyathilake CJ; Bell WC; Jones J; Henao OL; Heimburger DC; Niveleau A; Grizzle WE
Head Neck; 2005 Dec; 27(12):1061-7. PubMed ID: 16155917
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.
Grageda M; Silveyra P; Thomas NJ; DiAngelo SL; Floros J
Exp Lung Res; 2015 Mar; 41(2):93-102. PubMed ID: 25514367
[TBL] [Abstract][Full Text] [Related]
23. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
[TBL] [Abstract][Full Text] [Related]
24. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
Smith IM; Mydlarz WK; Mithani SK; Califano JA
Int J Cancer; 2007 Oct; 121(8):1724-8. PubMed ID: 17582607
[TBL] [Abstract][Full Text] [Related]
25. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
[TBL] [Abstract][Full Text] [Related]
26. Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Heimburger DC; Grizzle WE
Chest; 2003 Jan; 123(1):181-6. PubMed ID: 12527620
[TBL] [Abstract][Full Text] [Related]
27. Alterations of p14
López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C
Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733
[TBL] [Abstract][Full Text] [Related]
28. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
Zhang S; Kong WJ
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation markers of surfactant proteins in lung cancer.
Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
[TBL] [Abstract][Full Text] [Related]
30. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation and diet in cancer.
Johanning GL; Heimburger DC; Piyathilake CJ
J Nutr; 2002 Dec; 132(12):3814S-3818S. PubMed ID: 12468630
[TBL] [Abstract][Full Text] [Related]
32. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
[TBL] [Abstract][Full Text] [Related]
34. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
Shen Z; Chen X; Li Q; Zhou C; Xu Y; Yu R; Ye H; Li J; Duan S
Clin Biochem; 2016 Nov; 49(16-17):1278-1282. PubMed ID: 27521994
[TBL] [Abstract][Full Text] [Related]
35. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
[TBL] [Abstract][Full Text] [Related]
36. Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma.
Liu ZH; Liu JJ; Li SS; Yang XM
Cancer Invest; 2016; 34(2):105-13. PubMed ID: 26853927
[TBL] [Abstract][Full Text] [Related]
37. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.
Paluszczak J; Misiak P; Wierzbicka M; Woźniak A; Baer-Dubowska W
Oral Oncol; 2011 Feb; 47(2):104-7. PubMed ID: 21147548
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
[TBL] [Abstract][Full Text] [Related]
39. Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: a preliminary report.
Hanna E; MacLeod S; Vural E; Lang N
Am J Otolaryngol; 2001; 22(2):121-3. PubMed ID: 11283827
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation of the CYP1A1 enhancer is associated with smoking-induced genetic alterations in human lung.
Tekpli X; Zienolddiny S; Skaug V; Stangeland L; Haugen A; Mollerup S
Int J Cancer; 2012 Oct; 131(7):1509-16. PubMed ID: 22213191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]